VISTA expression is associated with a favorable prognosis in patients with high-grade serous ovarian cancer

Blockading programmed death ligand 1 (PD-L1) shows promising results in patients with some cancers, but not in those with ovarian cancer. V-domain Ig suppressor of T cell activation (VISTA) is a recently discovered immune checkpoint protein that suppresses T cell activation. This study aimed to inve...

Descripción completa

Detalles Bibliográficos
Autores principales: Zong, Liju, Zhou, Yuncan, Zhang, Ming, Chen, Jie, Xiang, Yang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6949319/
https://www.ncbi.nlm.nih.gov/pubmed/31781843
http://dx.doi.org/10.1007/s00262-019-02434-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6949319/
https://www.ncbi.nlm.nih.gov/pubmed/31781843
http://dx.doi.org/10.1007/s00262-019-02434-5

Ejemplares similares